Literature DB >> 21200049

Antiviral prescribing by office-based physicians during the 2009 H1N1 pandemic.

Adam L Hersh, Randall S Stafford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21200049      PMCID： PMC4016789          DOI： 10.7326/0003-4819-154-1-201101040-00019

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

2.  Changes in prescribing of antiviral medications for influenza associated with new treatment guidelines.

Authors:  Adam L Hersh; Judith H Maselli; Michael D Cabana
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308
  2 in total
  3 in total

1.  Design and implementation of a statewide influenza nurse triage line in response to pandemic H1N1 influenza.

Authors:  Alicen B Spaulding; Deborah Radi; Heather Macleod; Ruth Lynfield; Michelle Larson; Terri Hyduke; Peter Dehnel; Craig Acomb; Aaron S DeVries
Journal:  Public Health Rep       Date:  2012 Sep-Oct       Impact factor: 2.792

2.  Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand.

Authors:  Sunchai Payungporn; Wittaya Poomipak; Jarika Makkoch; Pornpimol Rianthavorn; Apiradee Theamboonlers; Yong Poovorawan
Journal:  J Virol Methods       Date:  2011-07-28       Impact factor: 2.014

3.  Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.

Authors:  Mariëtte Hooiveld; Tine van de Groep; Theo J M Verheij; Marianne A B van der Sande; Robert A Verheij; Margot A J B Tacken; Gerrit A van Essen
Journal:  BMC Pharmacol Toxicol       Date:  2013-10-21       Impact factor: 2.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.